Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2009-10-01
2010-10-12
Lewis, Patrick T (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S024000, C514S025000, C514S028000, C536S004100, C536S013000
Reexamination Certificate
active
07811998
ABSTRACT:
Novel analogues and derivatives of novobiocin are provided, including compounds having modifications to the amide side chain, coumarin ring, and sugar moieties. The compounds of the present invention are useful as heat shock protein 90 inhibitors, and may be used as anticancer and neuroprotective agents.
REFERENCES:
patent: 5382572 (1995-01-01), Afonso et al.
patent: 6579902 (2003-06-01), Demassey et al.
patent: 7622451 (2009-11-01), Blagg et al.
patent: 2007/0270452 (2007-11-01), Blagg et al.
patent: 2009/0163709 (2009-06-01), Blagg
patent: 2009/0187014 (2009-07-01), Blagg et al.
patent: WO2006-050501 (2006-05-01), None
International Search Report mailed Apr. 13, 2010 re: PCT/US10/24729.
Lubbers (2005) Thesis paper submitted to the University of Kansas in partial fulfillment for the degree of Masters of Science “Synthetic and computational efforts toward the understanding and development of novobiocin-derived inhibitors of Hsp90”.
Donnelly et al. (2008) Curr. Med. Chem. 15(26):2702-2717 “Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide-binding Pocket”.
Burlison et al. (2006) J. Am. Chem. Soc. 128(48):15529-15536 (epublished on Nov. 10, 2006) “Novobiocin: redesigning a DNA Gyrase Inhibitor for Selective Inhibition of Hsp90”.
Gebhart et al. (1985) Anitimicrobial Agents and Chemotherapy 27(1):55-59 “In Vitro Activities of 47 Antimicrobial Agents Against Three Campylobacter ssp. from Pigs”.
Gombert and Aulicino (1984) Antimicrobial Agents and Chemotherapy 26(6):933-934 “Susceptibility of Multiply Antibiotic-Resistant Pneumococci to the New Quinoline Antibiotics, Nalidixic Acid, Coumermycin, and Novobiocin”.
Le Bras et al. (2007) Med. Chem. 6189-6200 “New Novobiocin Analogues as Antiproliferative Agents in Breast Cancer Cells and Potential Inhibitors of Heat Shock Protein 90”.
Madhavan et al. (2003) Bioorg. Med. Chem. Lett. 13:2547 “Novel Coumarin Derivatives of Heterocyclic Compounds as Lipid Lowering Agents”.
Marcu et al. (2000) J. Biol. Chem 275:37181-37186 “The Heat Shock Protein 90 Antagonist Novobiocin Interacts with a Previously Unrecognized ATP-binding Domain in the Carboxy Terminis of the Chaperone”.
Messaoudi et al. (2008) Med. Chem. 8:761-782 “Recent Advances in Hsp90 Inhibitors as Antitumor Agents, Anti-Cancer Agents”.
Radanyi et al. (2009) Cancer Lett. 274:88-94 “Antiproliferative and Apoptotic Activities of Tosylcylconovobiocic Acids as Potent Heat Shock Protein 90 Inhibitors in Human Cancer Cells”.
Radanyi et al. (2008) Biorg. Med. Chem. Lett. 18:2495-2498 “Synthesis and Biological Activity of Simplified Denoviose-Coumarins Related to Novobiocin as Potent Inhibitors of Heat Shock Protein 90 (Hsp90)”.
Radanyi et al. (2009) Biochem. Biophys. Res. Comm. 379:514-518 “Tosylcyclonovobiocic Acids Promote Cleavage of the Hsp90-associated Cochaperone p23”.
Setlow et al. (1984) J. of Bacteriology 160(2):662-667 “Mechanism of Acquisition of Chromosomal Markers by Plasmids inHaemophilus influenzae”.
Shen et al. (2004) Bioorganic & Medicinal Chemistry Letters 14:5903-5906 “Syntheses of photolabile novobiocin analogues”.
Wells et al. (1971) J. Org. Chem. 36:1503-1506 “Facile synthesis of 3-acylaminoisocoumarins”.
Yu et al. (2004) J. Org. Chem. 69:7375-7378 “Synthesis of (−)-Noviose from 2,3-O-Isopropylidene-D-erythronolactol”.
Yu et al. (2005) J. Org. Chem. 70:5599-5605 “Synthesis of Mono- and Dihydroxylated Furanoses, Pyranoses, and an Oxepanose for the Preparation of Natural Product Analogue Libraries”.
Yu et al. (2005) J. Am. Chem. Soc. 127:12778-12779 “Hsp90 Inhibitors Identified from a Library of Novobiocin Analogues”.
Blagg Brian S.
Neckers Len
Yu Xiao Ming
Lewis Patrick T
Merchant & Gould
The United States of America as represented by the Department of
University of Kansas
LandOfFree
Novobiocin analogues as anticancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novobiocin analogues as anticancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novobiocin analogues as anticancer agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4160254